Alnylam Pharmaceuticals, Inc.
ALNY· Nasdaq
Quarterly figures for Alnylam Pharmaceuticals, Inc., with source filings when available.
69 quarters. Jun 30, 2009 to Jun 30, 2026. USD.
Alnylam Pharmaceuticals, Inc. has filed its 10-Q within 30 to 32 days of period end across its last 8 quarters. The 10-K runs 41 to 54 days.
Alnylam Pharmaceuticals, Inc. · CIK 1178670 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Jul 30, 2026 · market hours | Jul 30, 2026 | 30 d | 10-Q | $1.29B | +66.9% | $1.21 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| Apr 30, 2026 · market hours |
| Apr 30, 2026 |
| 30 d |
| 10-Q |
| — |
| — |
| — |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Jan 12, 2026 · market hours | Feb 12, 2026 | 43 d | 10-K | $1.10B | +84.9% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 30, 2025 · market hours | Oct 30, 2025 | 30 d | 10-Q | $1.25B | +149.3% | $1.84 | |
| Q2 2025 | Jun 30, 2025 | Jul 31, 2025 · market hours | Jul 31, 2025 | 31 d | 10-Q | $773.69M | +17.3% | -$0.55 | |
| Q1 2025 | Mar 31, 2025 | — | May 1, 2025 | 31 d | 10-Q | $594.19M | +20.2% | -$0.14 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Jan 13, 2025 · market hours | Feb 13, 2025 | 44 d | 10-K | $593.17M | +34.9% | — | |
| Q3 2024 | Sep 30, 2024 | — | Oct 31, 2024 | 31 d | 10-Q | $500.92M | −33.3% | -$0.87 | |
| Q2 2024 | Jun 30, 2024 | — | Aug 1, 2024 | 32 d | 10-Q | $659.83M | +107.0% | -$0.13 | |
| Q1 2024 | Mar 31, 2024 | — | May 2, 2024 | 32 d | 10-Q | $494.33M | +54.8% | -$0.52 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 15, 2024 · market hours | Feb 15, 2024 | 46 d | 10-K | $439.72M | +31.2% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 2, 2023 · market hours | Nov 2, 2023 | 33 d | 10-Q | $750.53M | +184.0% | $1.15 | |
| Q2 2023 | Jun 30, 2023 | Aug 3, 2023 · market hours | Aug 3, 2023 | 34 d | 10-Q | $318.75M | +41.8% | -$2.21 | |
| Q1 2023 | Mar 31, 2023 | May 4, 2023 · market hours | May 4, 2023 | 34 d | 10-Q | $319.29M | +49.7% | -$1.40 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 23, 2023 · market hours | Feb 23, 2023 | 54 d | 10-K | $335.04M | +29.6% | — | |
| Q3 2022 | Sep 30, 2022 | Oct 27, 2022 · market hours | Oct 27, 2022 | 27 d | 10-Q | $264.31M | +40.9% | -$3.32 | |
| Q2 2022 | Jun 30, 2022 | Jul 28, 2022 · market hours | Jul 28, 2022 | 28 d | 10-Q | $224.82M | +1.9% | -$2.29 | |
| Q1 2022 | Mar 31, 2022 | Apr 28, 2022 · market hours | Apr 28, 2022 | 28 d | 10-Q | $213.26M | +20.1% | -$2.00 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 10, 2022 · market hours | Feb 10, 2022 | 41 d | 10-K | $258.54M | +58.1% | — | |
| Q3 2021 | Sep 30, 2021 | Oct 28, 2021 · market hours | Oct 28, 2021 | 28 d | 10-Q | $187.63M | +49.1% | -$1.72 | |
| Q2 2021 | Jun 30, 2021 | Aug 3, 2021 · market hours | Aug 3, 2021 | 34 d | 10-Q | $220.55M | +112.1% | -$1.61 | |
| Q1 2021 | Mar 31, 2021 | Apr 29, 2021 · market hours | Apr 29, 2021 | 29 d | 10-Q | $177.57M | +78.5% | -$1.71 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | Feb 11, 2021 · market hours | Feb 11, 2021 | 42 d | 10-K | $163.56M | +128.2% | -$2.09 | |
| Q3 2020 | Sep 30, 2020 | Nov 5, 2020 · market hours | Nov 5, 2020 | 36 d | 10-Q | $125.85M | +79.6% | -$2.18 | |
| Q2 2020 | Jun 30, 2020 | Aug 6, 2020 · market hours | Aug 6, 2020 | 37 d | 10-Q | $103.96M | +132.5% | -$1.56 | |
| Q1 2020 | Mar 31, 2020 | May 6, 2020 · market hours | May 6, 2020 | 36 d | 10-Q | $99.48M | +198.8% | -$1.62 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | Feb 6, 2020 · market hours | Feb 13, 2020 | 44 d | 10-K | $71.68M | +240.8% | -$2.47 | |
| Q3 2019 | Sep 30, 2019 | Oct 31, 2019 · market hours | Oct 31, 2019 | 31 d | 10-Q | $70.06M | +3,286.2% | -$1.92 | |
| Q2 2019 | Jun 30, 2019 | Aug 6, 2019 · market hours | Aug 6, 2019 | 37 d | 10-Q | $44.71M | +49.5% | -$2.02 | |
| Q1 2019 | Mar 31, 2019 | May 1, 2019 · market hours | May 2, 2019 | 32 d | 10-Q | $33.29M | +52.0% | -$1.73 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | Feb 7, 2019 · after-hours | Feb 14, 2019 | 45 d | 10-K | $21.03M | −44.5% | -$2.09 | |
| Q3 2018 | Sep 30, 2018 | Nov 7, 2018 · market hours | Nov 7, 2018 | 38 d | 10-Q | $2.07M | −87.9% | -$2.43 | |
| Q2 2018 | Jun 30, 2018 | Aug 2, 2018 · market hours | Aug 2, 2018 | 33 d | 10-Q | $29.91M | +87.7% | -$1.63 | |
| Q1 2018 | Mar 31, 2018 | May 3, 2018 · after-hours | May 4, 2018 | 34 d | 10-Q | $21.90M | +15.5% | -$1.41 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | Feb 8, 2018 · market hours | Feb 15, 2018 | 46 d | 10-K | $37.92M | — | -$1.48 | |
| Q3 2017 | Sep 30, 2017 | Nov 7, 2017 · after-hours | Nov 7, 2017 | 38 d | 10-Q | $17.10M | — | -$1.34 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 9, 2017 | 40 d | 10-Q | $15.93M | — | -$1.34 | |
| Q1 2017 | Mar 31, 2017 | — | May 5, 2017 | 35 d | 10-Q | $18.96M | — | -$1.25 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Feb 15, 2017 | 46 d | 10-K | — | — | -$1.32 | |
| Q3 2016 | Sep 30, 2016 | — | Nov 3, 2016 | 34 d | 10-Q | — | — | -$1.21 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 4, 2016 | 35 d | 10-Q | — | — | -$1.05 | |
| Q1 2016 | Mar 31, 2016 | — | May 4, 2016 | 34 d | 10-Q | — | — | -$1.21 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | Feb 12, 2016 | 43 d | 10-K | — | — | -$1.07 | |
| Q3 2015 | Sep 30, 2015 | — | Nov 9, 2015 | 40 d | 10-Q | — | — | -$0.91 | |
| Q2 2015 | Jun 30, 2015 | — | Aug 7, 2015 | 38 d | 10-Q | — | — | -$0.85 | |
| Q1 2015 | Mar 31, 2015 | — | May 8, 2015 | 38 d | 10-Q | — | — | -$0.62 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Dec 31, 2014 | — | Feb 13, 2015 | 44 d | 10-K | — | — | -$0.28 | |
| Q3 2014 | Sep 30, 2014 | — | Nov 6, 2014 | 37 d | 10-Q | — | — | -$0.58 | |
| Q2 2014 | Jun 30, 2014 | — | Aug 8, 2014 | 39 d | 10-Q | — | — | -$0.58 | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | — | — | -$3.70 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013 | Dec 31, 2013 | — | — | — | — | — | — | -$0.51 | |
| Q3 2013 | Sep 30, 2013 | — | — | — | — | — | — | -$0.48 | |
| Q2 2013 | Jun 30, 2013 | — | — | — | — | — | — | -$0.29 | |
| Q1 2013 | Mar 31, 2013 | — | — | — | — | — | — | -$0.15 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012 | Dec 31, 2012 | — | — | — | — | — | — | -$1.20 | |
| Q3 2012 | Sep 30, 2012 | — | — | — | — | — | — | -$0.38 | |
| Q2 2012 | Jun 30, 2012 | — | — | — | — | — | — | -$0.25 | |
| Q1 2012 | Mar 31, 2012 | — | — | — | — | — | — | -$0.25 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011 | Dec 31, 2011 | — | — | — | — | — | — | -$0.33 | |
| Q3 2011 | Sep 30, 2011 | — | — | — | — | — | — | -$0.31 | |
| Q2 2011 | Jun 30, 2011 | — | — | — | — | — | — | -$0.33 | |
| Q1 2011 | Mar 31, 2011 | — | — | — | — | $20.90M | −14.9% | -$0.38 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Dec 31, 2010 | — | — | — | — | $21.19M | — | — | |
| Q3 2010 | Sep 30, 2010 | — | — | — | — | $27.67M | +14.1% | -$0.23 | |
| Q2 2010 | Jun 30, 2010 | — | — | — | — | $26.62M | +8.2% | -$0.35 | |
| Q1 2010 | Mar 31, 2010 | — | — | — | — | $24.56M | — | — | |
| FY 2009 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2009derived | Dec 31, 2009 | — | — | — | — | — | — | — | |
| Q3 2009 | Sep 30, 2009 | — | — | — | — | $24.25M | — | — | |
| Q2 2009 | Jun 30, 2009 | — | — | — | — | $24.60M | — | — | |